FEIM: Activist on the Register, Options Bullish, Stock Down 25% in a Month

Frequency Electronics enters the week in a sharp drawdown, off 25% over the past month to $64.25, yet the options market is running its most bullish posture in months.

The clearest divergence is in options. Calls have dramatically outpaced puts, with the put/call ratio falling to 0.52, more than 2.5 standard deviations below its 20-day average of 0.75. That is the lowest defensive positioning seen this year, the 52-week low in the PCR sits at 0.00 but the current reading is near the bullish extreme of recent history. The drop has been sharp and recent: two weeks ago the PCR was running above 0.80, suggesting a fast rotation into call exposure even as the stock slid.

Short positioning tells a less combative story. Short interest has eased consistently, falling roughly 10% on the week to 9.2% of the free float, and is down about 11% over the past month. Borrow conditions are undemanding: cost to borrow is 0.43%, down 18% on the week, and availability is ample at nearly 200% of short interest. The 52-week tightest point was 112%, so the current lending environment is loose by this name's own standards. Shorts are not pressing; they are covering.

The ownership picture carries a more charged element. An activist is on the register: Jonathan Brolin filed a Schedule 13D in late July disclosing an 11.3% stake of 1,242,941 shares. A 13D signals active intent rather than passive accumulation, and it is one of the most newsworthy facts about a stock. Separately, Edenbrook Capital, listed as both director and 10% owner, sold a combined 652,174 shares in late July at $57.50 per share, worth roughly $37.5 million. That is a significant exit from what was the largest institutional holder, and the institutional data shows Edenbrook's disclosed position has dropped to 10.8% from the prior higher level. BlackRock and Driehaus have crossed the 5% disclosure threshold on the passive side. As with all 13D/G positions, these stakes are as last disclosed around the threshold; a holder dropping below 5% may file nothing further. The net insider activity over the past 90 days shows net sales of $37.5 million, driven almost entirely by the Edenbrook exit rather than by management discretion. The CEO and CFO activity was limited to tax withholding transactions on vesting awards, which are compensation mechanics rather than conviction signals.

The Street view is thin coverage and somewhat dated. The consensus is a hold, split one buy and one hold, with a mean price target of $95.50 from Freedom Broker, who downgraded to hold in mid-September while simultaneously raising the target to $91. The $95.50 mean and a stock at $64 imply roughly 49% upside on paper, but with only two analysts covering the name and the most recent action already five weeks old, the target range is better read as a directional marker than a precise call. Craig-Hallum initiated at buy in September 2025 with a $43 target, which is now well below the current price: that data is stale and should not be weighted. The ORTEX short score is 59.9, holding in a narrow band around 60 for the past two weeks, placing the stock in the 7th percentile on short score rank within its sector, meaning limited short squeeze pressure from a positioning standpoint.

Earnings are next scheduled for December 11. The recent history is striking: the September 2026 print produced a one-day move of nearly 39% and a five-day move of roughly 38%, while an earlier event that same month also registered a near-identical jump. Those moves suggest the market treats FEIM prints as high-conviction catalysts rather than routine updates, a dynamic worth holding in mind as the stock resets lower into the next release date.

With an activist on the register, a fast options rotation toward calls, and shorts consistently covering even as the stock falls, the setup is one of competing signals: the price action says sellers are in control, but positioning says some participants are positioning for a reversal. The next pivot point is the December earnings date.